G-CSF Prevents Progression of Diabetic Nephropathy in Rat

PLoS ONE

Volumn 8, Issue 10, 2013, Pages

  So, Byung Im ^a   Song, Yi Sun ^a   Fang, Cheng Hu ^b,c   Park, Jun Young ^a   Lee, Yonggu ^b   Shin, Jeong Hun ^b   Kim, Hyuck ^b   Kim, Kyung Soo ^a,b  

^a Hanyang University   (South Korea)

^b Hanyang University College of Medicine   (South Korea)

^c YANBIAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 4; CREATININE; GRANULOCYTE COLONY STIMULATING FACTOR RECEPTOR; INTERLEUKIN 1BETA; MESSENGER RNA; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; SODIUM CHLORIDE; TRANSFORMING GROWTH FACTOR BETA1; COLLAGEN TYPE 6; GRANULOCYTE COLONY STIMULATING FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; BONE MARROW TRANSPLANTATION; CELL MOTILITY; COLLAGEN TYPE 4 GENE; CONTROLLED STUDY; CREATININE CLEARANCE; DIABETIC NEPHROPATHY; DRUG EFFICACY; DRUG MECHANISM; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE EXPRESSION; GLOMERULUS BASEMENT MEMBRANE THICKNESS; HISTOGENESIS; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; INTERLEUKIN 1BETA GENE; KIDNEY PARENCHYMA; MALE; MESANGIAL MATRIX EXPANSION; MICROALBUMINURIA; NONHUMAN; OTSUKA LONG EVANS TOKUSHIMA FATTY RAT; PODOCYTE FOOT PROCESS WIDTH; PROTEIN EXPRESSION; RAT; RENAL PROTECTION; RENAL SYSTEM PARAMETERS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSFORMING GROWTH FACTOR BETA1 GENE; ALLOGRAFT; ANIMAL; BIOSYNTHESIS; CELL MOTION; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; DRUG EFFECTS; GENE EXPRESSION REGULATION; GLOMERULUS BASEMENT MEMBRANE; GLOMERULUS FILTRATION RATE; METABOLISM; PATHOLOGY; PODOCYTE;

ALLOGRAFTS; ANIMALS; BONE MARROW CELLS; BONE MARROW TRANSPLANTATION; CELL MOVEMENT; COLLAGEN TYPE VI; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; GENE EXPRESSION REGULATION; GLOMERULAR BASEMENT MEMBRANE; GLOMERULAR FILTRATION RATE; GRANULOCYTE COLONY-STIMULATING FACTOR; INTERLEUKIN-1BETA; PODOCYTES; RATS; RATS, INBRED OLETF; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84885998937     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0077048     Document Type: Article

References (43)

1. Alsaad KO, Herzenberg AM, (2007) Distinguishing diabetic nephropathy from other causes of glomerulosclerosis: an update. J Clin Pathol 60: 18-26.
2. Giunti S, Barit D, Cooper ME, (2006) Mechanisms of diabetic nephropathy: role of hypertension. Hypertension 48: 519-526.
3. Fukuzawa Y, Watanabe Y, Inaguma D, Hotta N, (1996) Evaluation of glomerular lesion and abnormal urinary findings in OLETF rats resulting from a long-term diabetic state. J Lab Clin Med 128: 568-578.
4. Adler S, (1994) Structure-function relationships associated with extracellular matrix alterations in diabetic glomerulopathy. J Am Soc Nephrol 5: 1165-1172.
5. Mauer SM, Steffes MW, Ellis EN, Sutherland DE, Brown DM, et al. (1984) Structural-functional relationships in diabetic nephropathy. J Clin Invest 74: 1143-1155.
6. Zohlnhofer D, Ott I, Mehilli J, Schomig K, Michalk F, et al. (2006) Stem cell mobilization by granulocyte colony-stimulating factor in patients with acute myocardial infarction: a randomized controlled trial. JAMA 295: 1003-1010.
7. Sheridan WP, Morstyn G, Wolf M, Dodds A, Lusk J, et al. (1989) Granulocyte colony-stimulating factor and neutrophil recovery after high-dose chemotherapy and autologous bone marrow transplantation. Lancet 2: 891-895.
8. Lee ST, Chu K, Jung KH, Ko SY, Kim EH, et al. (2005) Granulocyte colony-stimulating factor enhances angiogenesis after focal cerebral ischemia. Brain Res 1058: 120-128.
9. Hou XW, Jiang Y, Wang LF, Xu HY, Lin HM, et al. (2009) Protective role of granulocyte colony-stimulating factor against adriamycin induced cardiac, renal and hepatic toxicities. Toxicol Lett 187: 40-44.
10. Yi-Sun S, Cheng-Hu F, Byung-Im S, Jun-Young P, Dae Won J, et al. (2013) Therapeutic effects of granulocyte-colony stimulating factor on non-alcoholic hepatic steatosis in the rat. Ann Hepatol 12: 115-122.
11. Lim YH, Joe JH, Jang KS, Song YS, So BI, et al. (2011) Effects of granulocyte-colony stimulating factor (G-CSF) on diabetic cardiomyopathy in Otsuka Long-Evans Tokushima fatty rats. Cardiovasc Diabetol 10: 92.
12. Flaquer M, Franquesa M, Vidal A, Bolanos N, Torras J, et al. (2012) Hepatocyte growth factor gene therapy enhances infiltration of macrophages and may induce kidney repair in db/db mice as a model of diabetes. Diabetologia 55: 2059-2068.
13. Kilkenny C, Browne WJ, Cuthi I, Emerson M, Altman DG, (2012) Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research. Vet Clin Pathol 41: 27-31.
14. Shoji E, Okumura T, Onodera S, Takahashi N, Harada K, et al. (1997) Gastric emptying in OLETF rats not expressing CCK-A receptor gene. Dig Dis Sci 42: 915-919.
15. Sugimoto K, Tsuruoka S, Fujimura A, (2001) Effect of enalapril on diabetic nephropathy in OLETF rats: the role of an anti-oxidative action in its protective properties. Clin Exp Pharmacol Physiol 28: 826-830.
16. Bennett PH, Haffner S, Kasiske BL, Keane WF, Mogensen CE, et al. (1995) Screening and management of microalbuminuria in patients with diabetes mellitus: recommendations to the Scientific Advisory Board of the National Kidney Foundation from an ad hoc committee of the Council on Diabetes Mellitus of the National Kidney Foundation. Am J Kidney Dis 25: 107-112.
17. Ziyadeh FN, (1993) The extracellular matrix in diabetic nephropathy. Am J Kidney Dis 22: 736-744.
18. Alpdogan O, Schmaltz C, Muriglan SJ, Kappel BJ, Perales MA, et al. (2001) Administration of interleukin-7 after allogeneic bone marrow transplantation improves immune reconstitution without aggravating graft-versus-host disease. Blood 98: 2256-2265.
19. Ho CC, Hau PM, Marxer M, Poon RY, (2010) The requirement of p53 for maintaining chromosomal stability during tetraploidization. Oncotarget 1: 583-595.
20. Tai CY, Strande LF, Eydelman R, Sheng X, VanTran JL, et al. (2004) Absence of graft-versus-host disease in the isolated vascularized bone marrow transplant. Transplantation 77: 316-319.
21. Song YS, Fang CH, So BI, Park JY, Jun DW, et al. (2013) Therapeutic effects of granulocyte-colony stimulating factor on non-alcoholic hepatic steatosis in the rat. Ann Hepatol 12: 115-122.
22. Kim SY, Lim AY, Jeon SK, Lee IS, Choue R, (2011) Effects of dietary protein and fat contents on renal function and inflammatory cytokines in rats with adriamycin-induced nephrotic syndrome. Mediators Inflamm 2011: 945123.
23. Blom D, Yamin TT, Champy MF, Selloum M, Bedu E, et al. (2010) Altered lipoprotein metabolism in P2Y(13) knockout mice. Biochim Biophys Acta 1801: 1349-1360.
24. Zhang HM, Dang H, Kamat A, Yeh CK, Zhang BX, (2012) Geldanamycin derivative ameliorates high fat diet-induced renal failure in diabetes. PLoS One 7: e32746.
25. Thomson SE, McLennan SV, Kirwan PD, Heffernan SJ, Hennessy A, et al. (2008) Renal connective tissue growth factor correlates with glomerular basement membrane thickness and prospective albuminuria in a non-human primate model of diabetes: possible predictive marker for incipient diabetic nephropathy. J Diabetes Complications 22: 284-294.
26. Deegens JK, Dijkman HB, Borm GF, Steenbergen EJ, van den Berg JG, et al. (2008) Podocyte foot process effacement as a diagnostic tool in focal segmental glomerulosclerosis. Kidney Int 74: 1568-1576.
27. van den Berg JG, van den Bergh Weerman MA, Assmann KJ, Weening JJ, Florquin S, (2004) Podocyte foot process effacement is not correlated with the level of proteinuria in human glomerulopathies. Kidney Int 66: 1901-1906.
28. Belmiro CL, Goncalves RG, Kozlowski EO, Werneck AF, Takyia CM, et al. (2011) Dermatan sulfate reduces monocyte chemoattractant protein 1 and TGF-beta production, as well as macrophage recruitment and myofibroblast accumulation in mice with unilateral ureteral obstruction. Braz J Med Biol Res 44: 624-633.
29. Jefferson JA, Shankland SJ, Pichler RH, (2008) Proteinuria in diabetic kidney disease: a mechanistic viewpoint. Kidney Int 74: 22-36.
30. Mogensen CE, (1987) Microalbuminuria as a predictor of clinical diabetic nephropathy. Kidney Int 31: 673-689.
31. Wolf G, Ziyadeh FN, (1999) Molecular mechanisms of diabetic renal hypertrophy. Kidney Int 56: 393-405.
32. Ziyadeh FN, (2004) Mediators of diabetic renal disease: the case for tgf-Beta as the major mediator. J Am Soc Nephrol 15Suppl 1: S55-57.
33. Navarro-Gonzalez JF, Mora-Fernandez C, (2008) The role of inflammatory cytokines in diabetic nephropathy. J Am Soc Nephrol 19: 433-442.
34. Harada M, Qin Y, Takano H, Minamino T, Zou Y, et al. (2005) G-CSF prevents cardiac remodeling after myocardial infarction by activating the Jak-Stat pathway in cardiomyocytes. Nat Med 11: 305-311.
35. Park KW, Kwon YW, Cho HJ, Shin JI, Kim YJ, et al. (2008) G-CSF exerts dual effects on endothelial cells-opposing actions of direct eNOS induction versus indirect CRP elevation. J Mol Cell Cardiol 45: 670-678.
36. Wei Q, Hill WD, Su Y, Huang S, Dong Z, (2011) Heme oxygenase-1 induction contributes to renoprotection by G-CSF during rhabdomyolysis-associated acute kidney injury. Am J Physiol Renal Physiol 301: F162-170.
37. Fang TC, Alison MR, Cook HT, Jeffery R, Wright NA, et al. (2005) Proliferation of bone marrow-derived cells contributes to regeneration after folic acid-induced acute tubular injury. J Am Soc Nephrol 16: 1723-1732.
38. Prodromidi EI, Poulsom R, Jeffery R, Roufosse CA, Pollard PJ, et al. (2006) Bone marrow-derived cells contribute to podocyte regeneration and amelioration of renal disease in a mouse model of Alport syndrome. Stem Cells 24: 2448-2455.
39. Petit I, Szyper-Kravitz M, Nagler A, Lahav M, Peled A, et al. (2002) G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4. Nat Immunol 3: 687-694.
40. Tavares AM, da Rosa Araujo AS, Baldo G, Matte U, Khaper N, et al. (2010) Bone marrow derived cells decrease inflammation but not oxidative stress in an experimental model of acute myocardial infarction. Life Sci 87: 699-706.
41. Ryan JM, Barry FP, Murphy JM, Mahon BP, (2005) Mesenchymal stem cells avoid allogeneic rejection. J Inflamm (Lond) 2: 8.
42. Ko GJ, Kang YS, Han SY, Lee MH, Song HK, et al. (2008) Pioglitazone attenuates diabetic nephropathy through an anti-inflammatory mechanism in type 2 diabetic rats. Nephrol Dial Transplant 23: 2750-2760.
43. Gabrilove JL, Jakubowski A, Scher H, Sternberg C, Wong G, et al. (1988) Effect of granulocyte colony-stimulating factor on neutropenia and associated morbidity due to chemotherapy for transitional-cell carcinoma of the urothelium. N Engl J Med 318: 1414-1422.